{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:43:30Z","timestamp":1792107810130,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.vaccine.2021.03.056","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T20:14:03Z","timestamp":1617308043000},"page":"2575-2583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics"],"prefix":"10.1016","volume":"39","author":[{"given":"Jiyeon","family":"Suh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1940-0210","authenticated-orcid":false,"given":"Taeyong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ki","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeehyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.03.056_b0005","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: A meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2021.03.056_b0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","article-title":"Global impact of varicella vaccination programs","volume":"15","author":"Varela","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.03.056_b0015","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.03.056_b0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/ciy1099","article-title":"Systematic review and meta-analysis of chickenpox vaccination and risk of herpes zoster: a quantitative view on the \u201cexogenous boosting hypothesis\u201d","volume":"69","author":"Harder","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.03.056_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066485","article-title":"Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review","volume":"8","author":"Ogunjimi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.03.056_b0030","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1542\/peds.78.4.723","article-title":"Population-based studies of varicella complications","volume":"78","author":"Guess","year":"1986","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2021.03.056_b0035","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1016\/j.vaccine.2017.07.090","article-title":"Evaluating the effectiveness of the universal immunization program against varicella in Japanese children","volume":"35","author":"Hattori","year":"2017","journal-title":"Vaccine"},{"issue":"202\u20136","key":"10.1016\/j.vaccine.2021.03.056_b0040","article-title":"Strong additional effect of a second varicella vaccine dose in children in Germany, 2009\u20132014","volume":"173","author":"Siedler","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2021.03.056_b0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/pch\/16.7.415","article-title":"Preventing varicella: Recommendations for routine two-dose varicella immunization in children","volume":"16","author":"Salvadori","year":"2011","journal-title":"Paediatrics & Child Health"},{"key":"10.1016\/j.vaccine.2021.03.056_b0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1542\/peds.2007-1089","article-title":"Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule","volume":"120","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2021.03.056_b0055","unstructured":"European Centre for Disease Prevention and Control, Varicella vaccination in the European Union. European Centre for Disease Prevention and Control; 2015"},{"key":"10.1016\/j.vaccine.2021.03.056_b0060","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1097\/INF.0b013e31828b7def","article-title":"Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses","volume":"32","author":"Bonanni","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2021.03.056_b0065","unstructured":"Lee SG. Korean national immunization survey, 2011. Osong, Republic of Korea: Korea Centers for Disease Control and Prevention; 2011."},{"key":"10.1016\/j.vaccine.2021.03.056_b0070","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1016\/j.vaccine.2019.07.086","article-title":"The changing epidemiology of herpes zoster over a decade in South Korea, 2006\u20132015","volume":"37","author":"Choi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.03.056_b0075","unstructured":"Korea Centers for Disease Control and Prevention. Infectious Diseases Surveillance Yearbook, 2019. Osong, Republic of Korea: Korea Centers for Disease Control and Prevention; 2020."},{"key":"10.1016\/j.vaccine.2021.03.056_b0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jinf.2010.04.001","article-title":"Seroprevalence rate after one dose of varicella vaccine in infants","volume":"61","author":"Kim","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2021.03.056_b0085","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/CVI.00645-13","article-title":"Varicella and varicella vaccination in South Korea","volume":"21","author":"Oh","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2021.03.056_b0090","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1080\/21645515.2016.1190056","article-title":"Seropositivity of varicella zoster virus in vaccinated Korean children and MAV vaccine group","volume":"12","author":"Choi","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.03.056_b0095","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","article-title":"Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster","volume":"28","author":"Brisson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.03.056_b0100","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"van Hoek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.03.056_b0105","unstructured":"Korean Statistical Information Service. Population projection for Korea (1960-2065); 2016."},{"key":"10.1016\/j.vaccine.2021.03.056_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"Mossong","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2021.03.056_b0115","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/jmv.21917","article-title":"Seroprevalence of varicella-zoster virus in Korea","volume":"82","author":"Choi","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2021.03.056_b0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3346\/jkms.2013.28.2.195","article-title":"Seroepidemiology of varicella-zoster virus in Korea","volume":"28","author":"Lee","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2021.03.056_b0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S0950268809990860","article-title":"Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia","volume":"138","author":"Gao","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.03.056_b0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2021.03.056_b0135","unstructured":"World Health Organization. SAGE Working Group on Varicella and Herpes Zoster Vaccines, Background Paper on Varicella Vaccine. 2014. https:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/april\/1_SAGE_varicella_background_paper_FINAL.pdf"},{"key":"10.1016\/j.vaccine.2021.03.056_b0140","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial","volume":"383","author":"Prymula","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2021.03.056_b0145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14760584.2018.1433999","article-title":"Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination a meta-analysis","volume":"17","author":"Yin","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.03.056_b0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12916-017-0983-5","article-title":"Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study","volume":"16","author":"Horn","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2021.03.056_b0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1473-3099(18)30716-3","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial","volume":"19","author":"Povey","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.03.056_b0160","unstructured":"Lee SG. Korean national immunization survey, 2013. Osong, Republic of Korea: Korea Centers for Disease Control and Prevention; 2013."},{"key":"10.1016\/j.vaccine.2021.03.056_b0165","unstructured":"Lee HR, Cha SH, Kim KH. Survey on efficacy and safety of varicella vaccine as a regular vaccine in Korea. Osong, Republic of Korea: Korea Centers for Disease Control and Prevention; 2005."},{"key":"10.1016\/j.vaccine.2021.03.056_b0170","unstructured":"Park SK. Nationwide vaccination coverage level: conceptual methodology and survey. Osong, Republic of Korea: Korea Centers for Disease Control and Prevention; 2009."},{"key":"10.1016\/j.vaccine.2021.03.056_b0175","doi-asserted-by":"crossref","first-page":"e1134","DOI":"10.1542\/peds.2013-0863","article-title":"Impact of a routine two-dose varicella vaccination program on varicella epidemiology","volume":"132","author":"Bialek","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2021.03.056_b0180","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6534a4","article-title":"Epidemiology of Varicella During the 2-Dose Varicella Vaccination Program \u2014 United States, 2005\u20132014","volume":"65","author":"Lopez","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.03.056_b0185","doi-asserted-by":"crossref","first-page":"20552","DOI":"10.2807\/1560-7917.ES2013.18.32.20552","article-title":"Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012","volume":"18","author":"Garcia Cenoz","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2021.03.056_b0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12916-017-0911-8","article-title":"The public health value of vaccines beyond efficacy: methods, measures and outcomes","volume":"15","author":"Wilder-Smith","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2021.03.056_b0195","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2021.03.056_b0200","doi-asserted-by":"crossref","unstructured":"Lee YH, Choe YJ, Cho S-i, Kang CR, Bang JH, Oh M-d, et al. Effectiveness of varicella vaccination program in preventing laboratory-confirmed cases in children in Seoul, Korea. J Korean Med Sci. 2016;31:1897-901. doi: 10.3346\/jkms.2016.31.12.1897.","DOI":"10.3346\/jkms.2016.31.12.1897"},{"key":"10.1016\/j.vaccine.2021.03.056_b0205","doi-asserted-by":"crossref","unstructured":"Weinmann S, Naleway AL, Koppolu P, Baxter R, Belongia EA, Hambidge SJ, et al. Incidence of Herpes Zoster Among Children: 2003-2014. Pediatrics. 2019;144. doi: 10.1542\/peds.2018-2917","DOI":"10.1542\/peds.2018-2917"},{"key":"10.1016\/j.vaccine.2021.03.056_b0210","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14760584.2019.1646129","article-title":"Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States","volume":"18","author":"Harpaz","year":"2019","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21003492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21003492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:54:23Z","timestamp":1759402463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21003492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":42,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0264410X21003492"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}